The Pittsburgh-based company's fourth-quarter earnings increased more than 80% from the same period in 2023, beating analysts ...

Truist Securities expressed continued confidence in Citigroup (NYSE:C) shares, reiterating a Buy rating with a steady price ...

Truist Securities updated its financial outlook for JPMorgan Chase & Co. (NYSE: NYSE:JPM), increasing the bank's price target ...

Exelixis (NASDAQ:EXEL) shares rose more than 2% intra-day today after Truist Securities analysts increased their price target ...

Albany International (NYSE:AIN – Get Free Report) had its target price lifted by research analysts at Truist Financial from ...

Additionally, Truist reiterated Buy rating on October 16 ... Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. The stock’s ...

Q4 2024 Earnings Call Transcript January 15, 2025 12:00 PM ET. Company Participants. Marius Merz - Head of IR Robin Vince - Presi ...

Truist analyst Terry Tillman downgraded Paycor HCM (PYCR) to Hold from Buy with a price target of $22.50, up from $20, following Paychex’s ...

In terms of valuation, Summit Therapeutics Inc’s market capitalization stands at $12.27 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s ...